BioSig Technologies, Inc. STEX Convertible Debt - Current
Convertible Debt - Current at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ConvertibleDebt.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s convertible debt - current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s convertible debt - current?
- BioSig Technologies, Inc. (STEX) reported convertible debt - current of $50M in Q1 2026.
- How has BioSig Technologies, Inc.'s convertible debt - current changed year-over-year?
- BioSig Technologies, Inc.'s convertible debt - current increased by 47519.0% year-over-year, from $105K to $50M.
- What is the long-term trend for BioSig Technologies, Inc.'s convertible debt - current?
- Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s convertible debt - current has grown at a 14.1% compound annual growth rate (CAGR), from $105K to $203K.
- What does convertible debt - current mean?
- This represents the portion of debt obligations that can be converted into equity and are scheduled for repayment or conversion within the next twelve months. It serves as a critical indicator of near-term liquidity requirements and potential equity dilution risk for investors. Monitoring this metric helps assess the company's ability to manage short-term capital structure obligations without compromising operational cash flow.